MarketInOut Stock Screener Log In | Sign Up
 

AbbVie Inc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 09/18/2026 16:00
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization464,823 mln
Float1,589 mln
Earnings Date10/23/2026

EPS

3.55
Stretched

P / E

74.35
Richly valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.5
Borderline

1-Year Forecast

279
Modest upside

Relative Strength

89 / 100
Strongly outperforming

Business Description

AbbVie is a global pharmaceutical company founded in 2012 and based in North Chicago, Illinois, that develops and sells treatments across a wide range of medical conditions. Its portfolio includes medicines for blood cancers, autoimmune and inflammatory diseases, neurological disorders, migraines, and eye conditions, as well as therapies for hepatitis C and digestive health. The company also has a strong presence in aesthetics, offering products such as Botox and the Juvederm collection for cosmetic and skin-related treatments.

Key Fundamentals

EPS3.55
P/E74.35
RPS36.39
ROIC14.14
ROA4.66
Interest Cover7.49
EBITDA, mln19,484
EV / EBITDA26.47
EV / EBIT44.40
Revenue, mln64,386
EV / Revenue8.01

Financial Strength

Altman Z-Score2.43
Piotroski F-Score 8 / 9
Beneish M-Score-2.5
Price to Intrinsic Value2.50
1-Year Target Price279
Shiller PE Ratio53.06
Short Ratio4.00
Short % of Float1.23

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.66% 93 / 100   
1 Month -0.76% 67 / 100   
2 Months 18.27% 92 / 100   
6 Months 29.97% 90 / 100   
1 Year 23.2% 77 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us